The consistent results between bioinformatics and biological investigation suggested convincing evidence that hub genes including GABARAPL1, SGTA, ARRB1, GPX8, and VCAM1 were abnormally expressed in IPF and could be utilized as a promising novel target for IPF treatment. Here, VCAM1 is linked to idiopathic pulmonary fibrosis.